Fundraising FoxAstrivax Therapeutics
4 known investors
Find your way into Astrivax Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
Ask Inge Van Hove to introduce you to Hanne Callewaert
You →Inge · together at Oxurion →Hanne
Sign up to find every way you can get introduced to Astrivax Therapeutics
- Your email: who you already know at Astrivax Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Astrivax Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Astrivax Therapeutics is a clinical-stage biopharmaceutical company developing immunotherapies to treat virus-driven cancers, particularly HPV16-associated cancers like cervical and head and neck cancer. The company's Launch-iT platform generates durable T-cell responses against virus-infected cells and is advancing toward clinical proof-of-concept.
Founders & leadership
Investors · 4
How we know: PMV's portfolio page · funding news · Not right? Tell us
Frequently asked questions
- What does Astrivax Therapeutics do?
- Astrivax Therapeutics is a clinical-stage biopharmaceutical company developing immunotherapies to treat virus-driven cancers, particularly HPV16-associated cancers like cervical and head and neck cancer. The company's Launch-iT platform generates durable T-cell responses against virus-infected cells and is advancing toward clinical proof-of-concept.
- Who founded Astrivax Therapeutics?
- Astrivax Therapeutics was founded by Hanne Callewaert.
- Who are Astrivax Therapeutics's investors?
- Astrivax Therapeutics's investors include Fund+, Korys, PMV, V-Bio Ventures.